What are the possible side effects of Cabergoline and how to deal with them

Cabergoline is an oral dopamine receptor agonist mainly used to treat hyperprolactinemia, Parkinson's disease and related diseases associated with elevated prolactin. It selectively activates pituitary dopamine D2 receptors and inhibits prolactin secretion, thereby improving menstrual disorders, infertility, galactorrhea and other symptoms. Although the efficacy is remarkable, some patients may experience multiple side effects while taking the drug. Therefore, rational identification of side effects and scientific countermeasures are crucial to ensuring efficacy and patient safety.
Common gastrointestinal reactions, one of the most common side effects of cabergoline, include nausea, vomiting, abdominal pain, bloating, and indigestion. Its occurrence is mainly related to the stimulating effect of drugs on dopamine receptors in the gastrointestinal tract. In order to alleviate these discomforts, patients should take the medicine after or with meals, avoid taking it on an empty stomach, and can adopt a light diet with small and frequent meals, and avoid greasy, spicy and irritating foods. For patients with severe nausea, doctors may recommend starting with a low dose initially and gradually increasing to a maintenance dose to improve tolerance.
Central nervous system-related side effects include headache, dizziness, drowsiness, fatigue, and symptoms of mild anxiety or depression. This type of side effect is mainly related to the activation of dopamine receptors in the brain by the drug, especially during the initial dose adjustment stage. Coping strategies include fixing the medication time, avoiding taking high doses at night, and avoiding standing up suddenly or changing positions quickly to prevent dizziness or fainting caused by orthostatic hypotension. If obvious drowsiness or mental status changes occur, you should seek medical evaluation promptly and adjust the dosage under the guidance of a doctor.

Cardiovascular-related reactions are an important safety concern with cabergoline, manifesting as orthostatic hypotension, blood pressure fluctuations, palpitations, and even arrhythmias in rare cases. Such reactions often occur during initial use or dose adjustment of the drug. Patients should monitor changes in blood pressure and heart rate during the initial period of medication. If necessary, the dose can be adjusted under the guidance of a doctor, and measures such as getting up gradually and avoiding prolonged standing or strenuous exercise can be taken to reduce the risk of hypotension. For patients with a history of cardiovascular disease, an electrocardiogram should be performed before use and reviewed regularly during use.

In addition, long-term use of cabergoline may cause adverse psychological or behavioral effects, such as impulsive behavior, irritability, or mood swings. In some patients with Parkinson's disease, impulse control disorders may occur, such as excessive shopping and increased sexual urges. Response measures include close observation of behavioral changes and regular psychological evaluation. If there are any abnormalities, the doctor should be notified promptly and the dose should be adjusted or the medication should be discontinued. For high-risk patients, physicians may initiate a lower dose initiation or intensive follow-up strategy to reduce the incidence of psychiatric and behavioral side effects.
Other adverse reactions include muscle cramps, joint pain, fatigue, dry mouth and mild liver function abnormalities. Generally, these reactions are mild to moderate and may gradually resolve as the body adapts to the dose. Symptoms can be alleviated by moderate exercise, maintaining adequate water and a balanced diet in daily life; for patients with abnormal liver function, liver function indicators should be monitored regularly, and the dose should be adjusted or medication discontinued if necessary.
In actual medication management, individualized dose adjustment and regular follow-up are the keys to ensuring safety and efficacy. Doctors usually start with a low dose and gradually adjust to a maintenance dose based on blood prolactin levels and side effects. At the same time, blood routine, liver and kidney function and blood pressure will be reviewed every few weeks. Patients should strictly follow the doctor's instructions and are not allowed to increase or decrease the dosage or stop the medication on their own to avoid a rebound of symptoms or an increased risk of side effects.
In short, cabergoline, as an important therapeutic drug for hyperprolactinemia and Parkinson's disease, has significant efficacy, but it may also cause various side effects such as gastrointestinal discomfort, central nervous system reactions, cardiovascular abnormalities, and psychological and behavioral changes. Through scientific medication strategies, such as starting at a low dose, gradually increasing, taking medication with meals, regularly monitoring blood pressure and blood indicators, and closely observing psychological and behavioral changes, patients can maximize the efficacy of the medication while reducing the risk of side effects and achieving safe and effective long-term management.
Reference: https://www.drugs.com/